Search Site
  • 0
    My Cart

    Click Here to Find How Many Items You Have Added:)

  1. Cat.No. Product Name Information
  2. GC13943 5-BDBD P2X4 receptor antagonist 5-BDBD Chemical Structure
  3. GC62346 UCB-9260 UCB-9260, an orally active compound, inhibits TNF signaling by stabilising an asymmetric form of the trimer. UCB-9260 Chemical Structure
  4. GC39573 NUCC-390 dihydrochloride NUCC-390 dihydrochloride is a novel and selective small-molecule?CXCR4 receptor?agonist. NUCC-390 dihydrochloride Chemical Structure
  5. GC17267 RN 1734 TRPV4 antagonist RN 1734 Chemical Structure
  6. GC68230 MitoSOX Red MitoSOX Red Chemical Structure
  7. GC15630 SR 57227 hydrochloride 5-HT3 receptor agonist SR 57227 hydrochloride Chemical Structure
  8. GA20810 Big Endothelin-3 (1-41) amide (human) Human big endothelin-3 increased arterial pressure, although with less potency and efficacy compared with Big ET-1. Big Endothelin-3 (1-41) amide (human) Chemical Structure
  9. GC15519 α-CGRP (human) Endogenous calcitonin gene-related peptide receptor (CGRP) agonist α-CGRP (human) Chemical Structure
  10. GD97531 Copric chloride dihydrate

    It deliquesces in humid air and weathers in dry air. It is easily soluble in water, ethanol and methanol, slightly soluble in acetone and ethyl acetate, and slightly soluble in ether. Its aqueous solution is acidic to stone core.

     Copric chloride dihydrate Chemical Structure
  11. GD01258 1-Acetylindole 1-Acetylindole Chemical Structure
  12. GC43458 1-O-hexadecyl-2-Dihomo-γ-Linolenoyl-sn-glycero-3-PC A PAF analog that contains DGLA 1-O-hexadecyl-2-Dihomo-γ-Linolenoyl-sn-glycero-3-PC Chemical Structure
  13. GC18693 Fascaplysin (chloride) A selective Cdk4 inhibitor Fascaplysin (chloride) Chemical Structure
  14. GC45013 Tenuazonic Acid (copper salt) A common mycotoxin food contaminant Tenuazonic Acid (copper salt) Chemical Structure
  15. GC11116 Thioetheramide-PC competitive, reversible inhibitor of secretory phospholipase A2 (sPLA2) Thioetheramide-PC Chemical Structure
  16. GC17001 Verruculogen Maxi-K potassium channels inhibitor Verruculogen Chemical Structure
  17. GC11025 (+)-MK 801 Maleate Potent NMDA antagonist (+)-MK 801 Maleate Chemical Structure
  18. GC16308 AZD-9291 Mutated forms EGFR inhibitor AZD-9291 Chemical Structure
  19. GC11037 Biotin-HPDP

    A sulfhydryl-reactive biotinylation reagent

     Biotin-HPDP Chemical Structure
  20. GC43021 C12FDG

    C12FDG is a fluorogenic substrate for β-galactosidase.

     C12FDG Chemical Structure
  21. GN10308 Chlorogenic acid

    Chlorogenic acid is a major phenolic compound in coffee and tea. 

     Chlorogenic acid Chemical Structure
  22. GC13261 Colchicine

    An inhibitor of microtubule polymerization

     Colchicine Chemical Structure
  23. GC12327 Corticosterone Corticosterone (17 deoxycortisol) is a glucocorticoid with oral activity and produced by adrenal cortex, which plays an important role in regulating the neuronal function of limbic system (including hippocampus, prefrontal cortex and amygdala). Corticosterone Chemical Structure
  24. GC33425 DiI (DiIC18(3)) A fluorescent neuronal tracer DiI (DiIC18(3)) Chemical Structure
  25. GC12520 Diphenyleneiodonium chloride Diphenyleneiodonium (DPI) chloride (DPIC), as a NADH/NADPH oxidase inhibitor, has possessing potent antimicrobial activity against Mtb and S. aureus. Diphenyleneiodonium chloride Chemical Structure
  26. GC16684 Docetaxel

    Docetaxel is an antineoplastic drug by inhibiting microtubule depolymerization, and attenuating of the effects of bcl-2 and bcl-xL gene expression.

     Docetaxel Chemical Structure
  27. GC12560 Dorsomorphin (Compound C) 2HCl AMPK inhibitor Dorsomorphin (Compound C) 2HCl Chemical Structure
  28. GC30485 Endothelin 1 swine, human Endothelin 1 (swine, human) is a 21aa peptide vasoconstrictor and agonist of endothelin (ET) receptors ETA and ETB (IC50s = 0.15 and 0.12 nM, respectively). Endothelin 1 swine, human Chemical Structure
  29. GC36048 FITC-Dextran (MW 10000) FITC-Dextran is a fluorescent probe for fluorescein isothiocyanate (FITC) dextran (Ex=495 nm; Em=525 nm). FITC-Dextran (MW 10000) Chemical Structure
  30. GC33715 Fluoxetine (LY-110140) A selective serotonin reuptake inhibitor for antidepressant research Fluoxetine (LY-110140) Chemical Structure
  31. GC19175 GSK-872 GSK-872 is a RIPK3 inhibitor. GSK-872 Chemical Structure
  32. GC19184 GSK484 hydrochloride A peptidylarginine deiminase 4 (PAD4) inhibitor GSK484 hydrochloride Chemical Structure
  33. GP11075 Imipenem

    Imipenem is a semisynthetic thienamycin. 

     Imipenem Chemical Structure
  34. GC41478 L-α-Hydroxyglutaric Acid L-α-Hydroxyglutaric Acid is an important metabolite in various domains of life. In mammals and plants, it is produced by lactate dehydrogenase (LDH) and malate dehydrogenase (MDH)-mediated 2-ketoglutarate (2-KG) reduction under hypoxic conditions. L-α-Hydroxyglutaric Acid Chemical Structure
  35. GC44401 Nicotinamide riboside Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, is converted to bioavailable NAD+, via nicotinamide riboside kinase (NRK) and NMNAT, or by the action of nucleoside phosphorylase and NAM salvage. Nicotinamide riboside Chemical Structure
  36. GC16533 Oligomycin Complex A inhibitor of ATP synthase Oligomycin Complex Chemical Structure
  37. GC44602 Peroxynitrite Formed in vivo by the reaction of NO with superoxide Peroxynitrite Chemical Structure
  38. GC36897 Phosal 50 PG Phosal 50 PG is a standardized phosphatidylcholine concentrate used in some lipid-based preparations to improve the absorption. Phosal 50 PG Chemical Structure
  39. GC13137 Pyocyanin Pyocyanin is a biologically active phenazine pigment Pyocyanin Chemical Structure
  40. GC32749 Sincalide (CCK-8) Sincalide(CCK-8) is a minor bioactive segment of CCK Sincalide (CCK-8) Chemical Structure
  41. GC17886 Stattic Stattic is the first non-peptide small molecule inhibitor of STAT3, which effectively inhibits STAT3 activation and nuclear translocation. Stattic Chemical Structure
  42. GC37885 Vancomycin Vancomycin is one of the potent antibiotics to perturb the gut microbiota. Vancomycin Chemical Structure
  43. GC12979 Vitamin C water soluble vitamin Vitamin C Chemical Structure
  44. GC11806 β-Glycerophosphate (sodium salt hydrate) A protein phosphatase inhibitor β-Glycerophosphate (sodium salt hydrate) Chemical Structure
  45. GC65942 MrgprX2 antagonist-8 MrgprX2 antagonist-8 (example 5b) is a MrgprX2 antagonist. MrgprX2 antagonist-8 can be used for the research of inflammatory disorders. MrgprX2 antagonist-8 Chemical Structure
  46. GC14285 RGFP966 Specific HDAC3 inhibitor RGFP966 Chemical Structure
  47. GF32529 3,4-Dihydro-2H-pyrido[1,2-a]pyrimidin-2-one 3,4-Dihydro-2H-pyrido[1,2-a]pyrimidin-2-one Chemical Structure
  48. GB10782 2'-MOE-ATP, 100mM Sodium Solution 2'-MOE-ATP is a 2'-O-MOE modified ATP analog, which can be used as an ATP substitute in RNA therapy to effectively reduce the immunogenicity and toxicity of RNA. 2'-MOE-ATP, 100mM Sodium Solution Chemical Structure
  49. GB10783 2-NH2-ATP, 100mM Sodium Solution 2-NH2-ATP is an amino-modified ATP analog and a weakly competitive ATP inhibitor with a K value of 2.3mM. 2-NH2-ATP, 100mM Sodium Solution Chemical Structure
  50. GB10784 3'O-Allyl-ATP, 100mM Sodium Solution 3'O-Allyl-ATP is an allyl-modified ATP analog that is a good substrate for RNA polymerase. 3'O-Allyl-ATP, 100mM Sodium Solution Chemical Structure
  51. GB10785 3'O-Allyl-CTP, 100mM Sodium Solution 3'O-Allyl-CTP is an allyl-modified CTP analog that is a good substrate for RNA polymerase. 3'O-Allyl-CTP, 100mM Sodium Solution Chemical Structure
  52. GB10786 3'O-Allyl-GTP, 100mM Sodium Solution 3'O-Allyl-UTP is an allyl-modified GTP analog that is a good substrate for RNA polymerase. 3'O-Allyl-GTP, 100mM Sodium Solution Chemical Structure
  53. GB10787 3'O-Allyl-UTP, 100mM Sodium Solution 3'O-Allyl-UTP is an allyl-modified UTP analog that is a good substrate for RNA polymerase. 3'O-Allyl-UTP, 100mM Sodium Solution Chemical Structure
  54. GB10788 5-Aminpropargyl UTP, 100mM Sodium Solution 5-Aminpropargyl UTP is a primary amine-modified analogue of naturally occurring UTP that can be used as a substrate for enzymatic reactions to introduce primary amine groups into RNA. 5-Aminpropargyl UTP, 100mM Sodium Solution Chemical Structure
  55. GB20005 5-Me-CTP,100mM Sodium Solution A CTP analogue used for in vitro mRNA synthesis 5-Me-CTP,100mM Sodium Solution Chemical Structure
  56. GB20004 5-OMe-UTP,100mM Sodium Solution 5-OMe-UTP is a methoxy-modified UTP analog commonly used to replace naturally occurring UTP during in vitro mRNA synthesis. 5-OMe-UTP,100mM Sodium Solution Chemical Structure
  57. GB10789 ATP(αS), 100mM Sodium Solution ATP(αS) is an ATP analogue, which is a mixture of ATP Rp and Sp isomers in a 1:1 ratio. ATP(αS), 100mM Sodium Solution Chemical Structure
  58. GB20116 Cy3-UTP, 10mM Sodium Solution Cy3-UTP is a Cyanine3-labeled UTP analog that can replace UTP for RNA labeling in in vitro transcription reactions. Cy3-UTP, 10mM Sodium Solution Chemical Structure
  59. GB20007 Cy5-UTP, 10mM Sodium Solution Cy5-UTP (Cyanine 5-aminoallyluridine-50-triphosphate) acts as a substrate for T7 RNA polymerase which could replace UTP with cyanine5-UTP. Cy5-UTP, 10mM Sodium Solution Chemical Structure
  60. GM10004 eGFP mRNA with N1-Me-pUTP (5’CAP) eGFP mRNA with N1-Me-pUTP (5’CAP) is a labeled green fluorescent protein mRNA produced by in vitro transcription, has a Cap 1 cap structure and a poly(A) tail, and contains N1-Me-pUTP modification eGFP mRNA with N1-Me-pUTP (5’CAP) Chemical Structure
  61. GM10001 eGFP mRNA(5’CAP) eGFP mRNA (5’CAP) is a green fluorescent protein mRNA produced by in vitro transcription and has a Cap 1 cap structure and a poly(A) tail. eGFP mRNA(5’CAP) Chemical Structure
  62. GM10005 Fluc mRNA with N1-Me-pUTP (5’CAP) Fluc mRNA with N1-Me-pUTP (5’CAP) is labeled luciferase mRNA produced by in vitro transcription, has a Cap 1 cap structure and a poly(A) tail, and contains N1-Me-pUTP modification. Fluc mRNA with N1-Me-pUTP (5’CAP) Chemical Structure
  63. GM10002 Fluc mRNA(5’CAP) Fluc mRNA (5’CAP) is labeled luciferase mRNA produced by in vitro transcription and has a Cap 1 cap structure and a poly(A) tail. Fluc mRNA(5’CAP) Chemical Structure
  64. GM10006 Fluc-eGFP mRNA with N1-Me-pUTP(5’CAP) Fluc-eGFP mRNA with N1-Me-pUTP is labeled luciferase mRNA produced by in vitro transcription, has a Cap 1 cap structure and a poly(A) tail, and contains N1-Me-pUTP modification. Fluc-eGFP mRNA with N1-Me-pUTP(5’CAP) Chemical Structure
  65. GM10003 Fluc-eGFP mRNA(5’CAP) Fluc-eGFP mRNA(5’CAP) is labeled luciferase mRNA produced by in vitro transcription, has a Cap 1 cap structure and a poly(A) tail. Fluc-eGFP mRNA(5’CAP) Chemical Structure
  66. GB20111 Fluorescein-12-UTP, 10mM Sodium Solution Fluorescein-12-UTP is a UTP analog of fluorescein, which can replace UTP for RNA labeling in in vitro transcription reactions. Fluorescein-12-UTP, 10mM Sodium Solution Chemical Structure
  67. GB20006 m6A-ATP,100mM Sodium Solution m6A-ATP is a base-modified analog of ATP and an adenosine agonist with an ED50 value of 17.250 μM. m6A-ATP,100mM Sodium Solution Chemical Structure
  68. GM10009 mcherry mRNA mCherry mRNA (5’CAP) is a commonly used fluorescent reporter gene in molecular biology research, with a Cap 1 cap structure and a poly(A) tail. mcherry mRNA Chemical Structure
  69. GM10010 mCherry mRNA with N1-Me-pUTP mCherry mRNA with N1-Me-pUTP is a commonly used fluorescent reporter gene in molecular biology research, with a Cap 1 cap structure and a poly(A) tail, and contains N1-Me-pUTP modification. mCherry mRNA with N1-Me-pUTP Chemical Structure
  70. GB20016 N1-Me-pUTP,100mM Sodium Solution N1-Me-pUTP,100mM Sodium Solution (1-Methylpseudouridine-5′-triphosphate) is a nucleobase-modified nucleotide, used for synthesizing mRNA with reduced immunogenicity and improved stability. N1-Me-pUTP,100mM Sodium Solution Chemical Structure
  71. GB10790 N7-Me-GTP, 100mM Sodium Solution N7-Me-GTP is a positively charged methyl-modified GTP that can be cotranscriptionally added to the 5′ cap. N7-Me-GTP, 100mM Sodium Solution Chemical Structure
  72. GM10011 OVA mRNA Ovalbumin OVA mRNA (5’CAP) is produced by in vitro transcription, has a Cap 1 cap structure and a poly(A) tail. OVA mRNA Chemical Structure
  73. GM10012 OVA mRNA with N1-Me-pUTP OVA mRNA with N1-Me-pUTP (5’CAP) is an ovalbumin mRNA produced by in vitro transcription, has a Cap 1 cap structure and a poly(A) tail, and contains N1-Me-pUTP modification. OVA mRNA with N1-Me-pUTP Chemical Structure
  74. GB20001 Pseudo-UTP,100mM Sodium Solution A modified nucleoside-5’-O-triphosphate, commonly used for drugable mRNA synthesis Pseudo-UTP,100mM Sodium Solution Chemical Structure
  75. GB20003 Pseudo-UTP,100mM Tris Solution A modified nucleoside-5’-O-triphosphate, commonly used for drugable mRNA synthesis Pseudo-UTP,100mM Tris Solution Chemical Structure
  76. GB56752 9,10-Diformylanthracene 9,10-Diformylanthracene Chemical Structure
  77. GB40031 sermorelin

    Sermorelin is a 29-residue N-terminal analog of growth hormone-releasing hormone (GHRH) that retains the ability to stimulate growth hormone (GH) release. Sermorelin (1 μg/kg, i.v.) increases serum GH levels in rats by approximately 17% compared with saline control after 15 minutes. It also increases GH release in pigs when administered at a dose of 250 ng/kg. Sermorelin (1 μM) increases proliferation of NCI-H727 human bronchial carcinoid cells by 30% and increases vascular endothelial growth factor (VEGF) secretion. It increases phosphorylation of focal adhesion kinase (FAK) and expression of VEGF in A549 lung cancer cells when used at a concentration of 0.1 μM. Formulations containing sermorelin have been used to diagnose and treat growth hormone deficiency.

     sermorelin Chemical Structure
  78. GC10663 Dihydrodaidzein estrogen receptor agonist Dihydrodaidzein Chemical Structure
  79. GN10590 Bakuchiol Bakuchiol Chemical Structure
  80. GC68832 Carlumab Carlumab Chemical Structure
  81. GC11194 Biotin A coenzyme of carboxylase enzymes Biotin Chemical Structure
  82. GM10008 Cas9 mRNA with N1-Me-pUTP Cas9 mRNA with N1-Me-pUTP (5’CAP) is a DNA endonuclease mRNA produced by in vitro transcription. It has a Cap 1 cap structure and a poly(A) tail, and contains N1-Me-pUTP modification. Cas9 mRNA with N1-Me-pUTP Chemical Structure
  83. GM10007 Cas9 mRNA 5-Propargylamino-ddUTP, a nucleoside molecule that can be used to synthesis of cyanine dye-nucleotide conjugate which is used in nucleic acid labeling or sequence analysis. Cas9 mRNA Chemical Structure
  84. GC15344 SP 600125 JNK1/2/3 inhibitor SP 600125 Chemical Structure
  85. GC26118 Dispase II

    Dispase, a neutral protease, is a non-specific metalloprotease, which is used to digest extracellular matrix from different tissues or organs, release and prepare primary single cells.

     Dispase II Chemical Structure
  86. GC10769 SB269970 HCl 5-HT7 receptor antagonist,potent and selective SB269970 HCl Chemical Structure
  87. GN10272 Monotropein Monotropein Chemical Structure
  88. GC15365 N-Acetylserotonin an agonist at the melatonin receptors MT1, MT2, and MT3 N-Acetylserotonin Chemical Structure
  89. GC39640 GPLGIAGQ TFA GPLGIAGQ TFA, a MMP2-cleavable polypeptide, is used as a stimulus-sensitive linker in both liposomal and micellar nanocarriers for MMP2-triggered tumor targeting. GPLGIAGQ TFA can be used to synthesis unique MMP2-targeted photosensitizer in photodynamic therapy (PDT). GPLGIAGQ TFA Chemical Structure
  90. GC13104 4E1RCat Dual inhibitor of eIF4E:eIF4G and eIF4E:4E-BP1 interaction 4E1RCat Chemical Structure
  91. GK10009 BCA Protein Assay Kit Bicinchoninic Acid Kit for Protein Determination BCA Protein Assay Kit Chemical Structure
  92. GB40285 Muscimol HBr

    Muscimol HBr (18174-72-6) is a GABA-A receptor agonist.

     Muscimol HBr Chemical Structure
  93. GP29066 UBA5 Human (His)

    Ubiquitin-like modifier-activating enzyme 5; ThiFP1; UFM1-activating enzyme; Ubiquitin-activating enzyme E1 domain-containing protein 1; UBE1DC1; UBA5

     UBA5 Human (His) Chemical Structure
  94. GP29065 UBE2D1 Human (GST)

    Ubiquitin-conjugating enzyme E2 D1; Stimulator of Fe transport; SFT; UBC4/5 homolog; UbcH5; Ubiquitin carrier protein D1; Ubiquitin-conjugating enzyme E2(17)KB 1; Ubiquitin-conjugating enzyme E2-17 kDa 1; Ubiquitin-protein ligase D1; SFT; UBC5A; UBCH5; UBCH5A

     UBE2D1 Human (GST) Chemical Structure
  95. GC63776 SIM1 SIM1 is a potent von Hippel-Lindau (VHL)-based trivalent PROTAC capable of degradation for all BET family members, with preference for BRD2 degradation (IC50=1.1 nM; Kd=186 nM). SIM1 shows sustained anti-cancer activity. SIM1 Chemical Structure
  96. GC68918 Cy5.5-SE

    Cy5.5-SE (Cyanine5.5 NHS ester) is a CY dye.

     Cy5.5-SE Chemical Structure
  97. GC42781 AMC Arachidonoyl Amide A fluorometric FAAH substrate used for enzyme activity measurement AMC Arachidonoyl Amide Chemical Structure
  98. GC37779 Theaflavin-3-gallate A polyphenolic flavonoid with diverse biological activities Theaflavin-3-gallate Chemical Structure
  99. GC12485 Ro 67-7476 positive allosteric modulator of mGlu1 receptors Ro 67-7476 Chemical Structure
  100. GC38504 D-Ala-Lys-AMCA hydrochloride D-Ala-Lys-AMCA hydrochloride is a known proton-coupled oligopeptide transporter 1 (PEPT1) substrate that emits blue fluorescence. D-Ala-Lys-AMCA hydrochloride may be transported into liver cancer cells and Caco-2 cells based on fluorescence analysis. D-Ala-Lys-AMCA hydrochloride Chemical Structure
  101. GC35057 14-Deoxyandrographolide A diterpene lactone with diverse biological properties 14-Deoxyandrographolide Chemical Structure

Items 1 to 100 of 200 total

per page
  1. 1
  2. 2

Set Descending Direction